UiPath Inc. (PATH) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 1, 2026, UiPath Inc. (PATH) trades at a price-to-earnings ratio of -82.5x, with a stock price of $10.73 and trailing twelve-month earnings per share of $0.42.
The current P/E is 141% below its 5-year average of 203.5x. Over the past five years, PATH's P/E has ranged from a low of 37.6x to a high of 369.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 25.2x, PATH trades at a 427% discount to its sector peers. The sector includes 345 companies with P/E ratios ranging from 0.0x to 199.1x.
Relative to the broader market, PATH trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PATH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Developer tools and automation peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
SNPSSynopsys, Inc. | $79B | 51.5 | 3.82Best | -45% |
APPNAppian Corporation | $2B | 1333.5 | - | +102%Best |
MLGOMicroAlgo Inc. | $36M | 6.5Lowest | - | +100% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Fri Oct 31 2025 00:00:00 GM | $15.86 | $0.42 | 37.6x | -82% |
| FY2026 Q2 | $11.75 | $0.03 | 369.5x | +82% |
Average P/E for displayed period: 203.5x
See PATH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PATH Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare PATH vs NVDA
See how PATH stacks up against sector leader NVIDIA Corporation.
Start ComparisonFrequently Asked Questions
Is PATH stock overvalued or undervalued?
PATH trades at -82.5x P/E, below its 5-year average of 203.5x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does PATH's valuation compare to peers?
UiPath Inc. P/E of -82.5x compares to sector median of 25.2x. The discount suggests lower growth expectations or higher risk.
What is PATH's PEG ratio?
PATH PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.